Holding(s) in Company

RNS Number : 5751P
Dechra Pharmaceuticals PLC
26 March 2009
 




For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:


Dechra Pharmaceuticals plc



2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


X


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:


Lloyds Banking Group plc


4. Full name of shareholder(s) (if different from 3):


See Section 9


5. Date of transaction (and date on which the threshold is crossed or reached if different):


25 March 2009


6. Date on which issuer notified:


26 March 2009


7. Threshold(s) that is/are crossed or reached:


Decrease to below 5% Direct/Indirect



8: Notified Details

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights


Direct


Indirect


Direct


Indirect

Ord 1p

 

GB0009633180


3,283,473


3,283,473


N/A


N/A


N/A


N/A


N/A




B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights


N/A








Total (A+B)


Number of voting rights

Percentage of voting rights


N/A


N/A




9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:


N/A


Proxy Voting:


10. Name of proxy holder:


N/A

11. Number of voting rights proxy holder will cease to hold:



N/A

12. Date on which proxy holder will cease to hold voting rights:



N/A


13. Additional information:


Notification using the total voting rights figure of

65,500,592

14 Contact name:


Kenny Melville

15. Contact telephone number:


0131 243 8671


For notes on how to complete form TR-1 please see the FSA website. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLZGGZFNVZGLZM
UK 100